Revance

RVNC NASDAQ
12.83
-0.04
-0.31%
Opening 11:09 07/19 EDT
Open
12.83
Prev Close
12.87
High
13.05
Low
12.81
Volume
90.88K
Avg Vol (3M)
416.79K
52 Week High
30.60
52 Week Low
10.37
% Turnover
0.21%
Market Cap
564.60M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Revance RVNC stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Revance Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the development, manufacturing and commercialization of botulinum toxin products for multiple aesthetic and therapeutic indications. Its peptide technology enables delivery of botulinum toxin type A through two investigational drug product candidates, DaxibotulinumtoxinA for Injection (RT002), or RT002 injectable, and DaxibotulinumtoxinA Topical Gel (RT001), or RT001 topical. It is engaged in the clinical development for RT002 injectable. RT002 injectable utilizes botulinum toxin-peptide complex in a saline-based formulation. In RT002 injectable, the peptide interacts with both extracellular structures and cell surface receptors in the targeted muscle. This interaction restricts the toxin molecule to the target site and reduces unwanted spread to other neighboring muscles. It is focusing on developing RT002 for the treatment of glabellar lines, cervical dystonia and plantar fasciitis.
MORE >

Recently

Name
Price
%Change